(V858) |
Single-center experience using second generation devices for transapical transcatheter aortic valve implantation |
|
H. Treede, L. Conradi, M. Seiffert, R. Schnabel, J. Schirmer, D. Koschyk, S. Baldus, H. Reichenspurner, S. Blankenberg, P. Diemert (Hamburg, Köln) |
(V859) |
The Impact of Post-implant SAPIEN XT Geometry and Position on Conduction Disturbances, Hemodynamic Performance and Paravalvular Regurgitation |
|
R. Binder, J. G. Webb, S. Toggweiler, M. Freeman, M. Barbanti, A. B. Willson, D. Alhassan, C. J. Hague, D. Wood, J. Leipsic (Vancouver, CA) |
(V860) |
Implantation of a JenaValve transcatheter heart valve in a series of patients with pure aortic regurgitation |
|
M. Seiffert, D. Koschyk, J. Schirmer, R. Schnabel, L. Conradi, H. Reichenspurner, S. Blankenberg, H. Treede, P. Diemert (Hamburg) |
(V861) |
Evaluation of the next generation SAPIEN XT transcatheter heart valve (THV) and delivery system. Data from the PREVAIL TF (EU) trial. |
|
S. Sack, J. Menne, A. Vahanian, A. Cribier, B. DeBruyne, T. Lefevre, M. Thomas, J. Fajadet, G. C. Schuler, D. MacCarthy, J. Schofer, G. Schymik (München, Leipzig, Hamburg, Karlsruhe; Paris, Rouen, Massy, Toulouse, FR; Aalst, BE; London, UK) |
(V862) |
Long-term performance of a nonmetallic, retrievable and repositionable aortic valve in patients with severe aortic stenosis 4 Year Follow-Up of the 22 F-Direct Flow Medical Valve |
|
K. Bijuklic, T. Tübler, H. Reichenspurner, H. Treede, R. Low, E. Grube, J. Schofer (Hamburg, Bonn; Sacramento, US) |
(V863) |
Protektion der Koronararterien bei der Behandlung degenerierter Mitroflow-Prothesen mittels Transkatheter Aortenklappen „valve in valve“-Implantation. |
|
J. C. Horstkotte, R. Müller, P. Boekstegers (Siegburg) |